Form 4 for LLY Lilly (Eli)
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0000059478-22-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | LLY | Ricks David A | Pres, CEO, Dir | M - OptEx | $0.00 | +56.2K | 424.9K | +15% | $0 |
| D | 2022-02-03 | 2022-02-01 | LLY | Ricks David A | Pres, CEO, Dir | F - Tax | $245.39 | -25.2K | 399.8K | -6% | -$6.18M |
| D | 2022-02-03 | 2022-02-01 | LLY | Ricks David A | Pres, CEO, Dir | M - OptEx | $0.00 | -56.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | M | A | 56,205 | $0.00 | 424,949 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-01 | F | D | 25,170 | $245.39 | 399,779 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-02-01 | M | D | 56,205 | $0.00 | 0 | D | — · 2022-02-01 to 2022-02-01 | 56,205 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |